Back

Cardiac fibroblast activation in Fabry disease on 18F-fibroblast activation protein inhibitor positron emission tomography/computed tomography imaging

European Heart Journal - Case Reports

18 October 2022
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Fibroblast activation following myocardial infarction and left ventricular remodelling
19 May 2024
thumbnail
Congress Session
Could It be Fabry cardiomyopathy?
30 August 2024
thumbnail
Congress Presentation
Mid-term benefit of pharmacological chaperone therapy on cardiac manifestation in Japanese Fabry disease
29 August 2025
thumbnail
Congress Presentation
Myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging with contrast-enhancement in patients with Fabry disease.
6 May 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources